HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pavlina Jimbei Selected Research

REP 2139

1/2020Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy.
12/2017Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pavlina Jimbei Research Topics

Disease

6Infections
01/2022 - 12/2017
4Coinfection
01/2022 - 12/2017
3Chronic Hepatitis B
11/2021 - 12/2017
2Hepatitis B
11/2021 - 01/2021
1Virus Diseases (Viral Diseases)
01/2022
1Neutropenia
01/2020
1Thrombocytopenia (Thrombopenia)
01/2020
1Communicable Diseases (Infectious Diseases)
12/2017

Drug/Important Bio-Agent (IBA)

5Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 12/2017
4RNA (Ribonucleic Acid)IBA
01/2022 - 12/2017
3PolymersIBA
01/2022 - 01/2021
3Nucleic AcidsIBA
01/2022 - 01/2021
3Hepatitis B e AntigensIBA
01/2022 - 12/2017
2Alanine Transaminase (SGPT)IBA
01/2022 - 11/2021
2Tenofovir (Viread)FDA Link
11/2021 - 01/2020
2Antigen-Antibody Complex (Immune Complex)IBA
11/2021 - 01/2021
2AntigensIBA
11/2021 - 01/2021
2InterferonsIBA
11/2021 - 01/2021
2N-(4-aminophenethyl)spiroperidol (NAPS)IBA
11/2021 - 01/2020
2Transaminases (Aminotransferases)IBA
01/2021 - 12/2017
2peginterferon alfa-2a (Pegasys)FDA Link
01/2020 - 12/2017
2REP 2139IBA
01/2020 - 12/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2022
1Protein Isoforms (Isoforms)IBA
01/2022
1pgRNAIBA
01/2021
1Surface Antigens (Surface Antigen)IBA
12/2017
1Hepatitis delta Antigens (HDAg)IBA
12/2017

Therapy/Procedure

6Therapeutics
01/2022 - 12/2017
1Immunotherapy
12/2017